First reported at 34,257 shares this quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|---|
| 2021-12-31 | 0 |
| 2023-12-31 | 168398 |
| 2024-03-31 | 0 |
| 2024-06-30 | 43849 |
| 2024-09-30 | 14463 |
| 2024-12-31 | 26938 |
| 2025-03-31 | 0 |
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Shares | Change | % of reported 13F | Reported value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
| Q1 2025 | Reduced | 0 | -72,046 (-100.0%) | 0 | $0 | 2025-05-15 | |
| Q4 2024 | Added | 72,046 | +48,336 (203.9%) | < 0.01% | $26,938 | 2025-02-14 | |
| Q3 2024 | Reduced | 23,710 | -10,547 (-30.8%) | < 0.01% | $14,463 | 2024-11-14 | |
| Q2 2024 | New | 34,257 | +34,257 (0.0%) | < 0.01% | $43,849 | 2024-08-14 | |
| Q1 2024 | Reduced | 0 | -57,084 (-100.0%) | 0 | $0 | 2024-05-15 | |
| Q4 2023 | New | 57,084 | +57,084 (0.0%) | < 0.01% | $168,398 | 2024-02-14 | |
| Q4 2021 | Reduced | 0 | -9,438 (-100.0%) | 0 | $0 | 2022-02-14 | |
|
Five years are shown. A free account unlocks the complete reported history.
Unlock full history
|
|||||||
Who else reported the position
95 managers reported BIOXCEL THERAPEUTICS INC COM ( for Q2 2024.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| ARMISTICE CAPITAL LLC | Added | 2,987,000 | +2,616,027 | 0.05% | $3,823,360 | 2 qtrs |
| FMR LLC | Reduced | 2,205,172 | -288,944 | < 0.01% | $2,822,621 | 26 qtrs |
| VANGUARD GROUP INC | Reduced | 970,430 | -128,945 | < 0.01% | $1,242,151 | 26 qtrs |
| BlackRock Inc | Reduced | 440,685 | -887,376 | < 0.01% | $564,077 | 25 qtrs |
| BNP PARIBAS FINANCIAL MARKETS | Added | 273,135 | +251,385 | < 0.01% | $349,613 | 21 qtrs |
| GEODE CAPITAL MANAGEMENT LLC | Reduced | 266,719 | -191,201 | < 0.01% | $341,470 | 22 qtrs |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | Added | 203,615 | +12,645 | < 0.01% | $260,627 | 21 qtrs |
| NORTHERN TRUST CORPORATION | Reduced | 194,953 | -16,649 | < 0.01% | $249,540 | 22 qtrs |
| SUSQUEHANNA INTERNATIONAL GROUP LLP | Added | 173,318 | +83,128 | < 0.01% | $221,847 | 17 qtrs |
| WELLS FARGO & COMPANY MN | Added | 133,676 | +10,590 | < 0.01% | $171,105 | 25 qtrs |
Filing details and methodology As reported
- Report period
- June 30, 2024
- Filed
- August 14, 2024
- Filing type
- 13F-HR
- Position type
- COM
Voting authority reported
- Sole
- 0
- Shared
- 34,257
- None
- 0
“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.